ALT 0 3 0 3 B-clinical_variable
≥ 4 5 4 5 O
2 6 7 6 7 B-lower_bound
x 8 9 8 9 I-lower_bound
ULN 10 13 10 13 I-lower_bound
at 14 16 14 16 O
screening 17 26 17 26 O
( 27 28 27 28 O
girls 28 33 28 33 O
≥ 34 35 34 35 O
46 36 38 36 38 B-lower_bound
, 38 39 38 39 O
boys 40 44 40 44 O
≥ 45 46 45 46 O
54 47 49 47 49 B-lower_bound
) 49 50 49 50 O

Acute 0 5 51 56 B-chronic_disease
illness 6 13 57 64 I-chronic_disease
within 14 20 65 71 O
past 21 25 72 76 B-upper_bound
2 26 27 77 78 I-upper_bound
weeks 28 33 79 84 I-upper_bound
prior 34 39 85 90 I-upper_bound
to 40 42 91 93 O
enrollment 43 53 94 104 O
( 54 55 105 106 O
defined 55 62 106 113 O
as 63 65 114 116 O
fever 66 71 117 122 B-clinical_variable
> 72 73 123 124 O
100.4ºF 74 81 125 132 B-lower_bound
) 81 82 132 133 O

Change 0 6 134 140 O
in 7 9 141 143 O
supplement 10 20 144 154 O
or 21 23 155 157 O
anti 24 28 158 162 B-treatment
- 28 29 162 163 I-treatment
oxidant 29 36 163 170 I-treatment
therapy 37 44 171 178 I-treatment
within 45 51 179 185 O
past 52 56 186 190 B-upper_bound
90 57 59 191 193 I-upper_bound
days 60 64 194 198 I-upper_bound
( 65 66 199 200 O
must 66 70 200 204 O
be 71 73 205 207 O
on 74 76 208 210 O
a 77 78 211 212 O
stable 79 85 213 219 O
dose 86 90 220 224 O
and 91 94 225 228 O
willing 95 102 229 236 O
to 103 105 237 239 O
continue 106 114 240 248 O
it 115 117 249 251 O
throughout 118 128 252 262 O
the 129 132 263 266 O
trial 133 138 267 272 O
or 139 141 273 275 O
not 142 145 276 279 O
on 146 148 280 282 O
any 149 152 283 286 O
vitamin 153 160 287 294 O
or 161 163 295 297 O
supplement 164 174 298 308 O
, 174 175 308 309 O
includes 176 184 310 318 O
SAMe 185 189 319 323 B-treatment
, 189 190 323 324 O
vitamin 191 198 325 332 B-treatment
E 199 200 333 334 I-treatment
, 200 201 334 335 O
betaine 202 209 336 343 B-treatment
, 209 210 343 344 O
Milk 211 215 345 349 B-treatment
thistle 216 223 350 357 I-treatment
etc 224 227 358 361 O
) 227 228 361 362 O

Current 0 7 363 370 O
enrollment 8 18 371 381 O
in 19 21 382 384 O
another 22 29 385 392 B-treatment
therapeutic 30 41 393 404 I-treatment
clinical 42 50 405 413 I-treatment
trial 51 56 414 419 I-treatment
or 57 59 420 422 O
receipt 60 67 423 430 O
of 68 70 431 433 O
an 71 73 434 436 O
investigational 74 89 437 452 O
study 90 95 453 458 O
drug 96 100 459 463 O
within 101 107 464 470 O
6 108 109 471 472 B-upper_bound
months 110 116 473 479 I-upper_bound
prior 117 122 480 485 I-upper_bound
to 123 125 486 488 O
study 126 131 489 494 O
enrollment 132 142 495 505 O

Current 0 7 506 513 O
gastrointestinal 8 24 514 530 B-chronic_disease
( 25 26 531 532 I-chronic_disease
GI 26 28 532 534 I-chronic_disease
) 28 29 534 535 I-chronic_disease
bleeding 30 38 536 544 I-chronic_disease

Evidence 0 8 545 553 O
of 9 11 554 556 O
other 12 17 557 562 O
chronic 18 25 563 570 B-chronic_disease
liver 26 31 571 576 I-chronic_disease
disease 32 39 577 584 I-chronic_disease
other 40 45 585 590 O
than 46 50 591 595 O
NAFLD 51 56 596 601 B-chronic_disease
( 57 58 602 603 O
Hepatitis 58 67 603 612 B-chronic_disease
B 68 69 613 614 I-chronic_disease
and 70 73 615 618 I-chronic_disease
C 74 75 619 620 I-chronic_disease
, 75 76 620 621 O
Alpha-1 77 84 622 629 B-chronic_disease
antitrypsin 85 96 630 641 I-chronic_disease
, 96 97 641 642 O
Wilson 98 104 643 649 B-chronic_disease
's 104 106 649 651 I-chronic_disease
disease 107 114 652 659 I-chronic_disease
) 114 115 659 660 O

Nonalcoholic 0 12 661 673 B-chronic_disease
fatty 13 18 674 679 I-chronic_disease
liver 19 24 680 685 I-chronic_disease
disease 25 32 686 693 I-chronic_disease
( 33 34 694 695 I-chronic_disease
NAFLD 34 39 695 700 I-chronic_disease
) 39 40 700 701 I-chronic_disease
diagnosis 41 50 702 711 O
confirmed 51 60 712 721 O
by 61 63 722 724 O
liver 64 69 725 730 B-treatment
biopsy 70 76 731 737 I-treatment
or 77 79 738 740 O
MRI 80 83 741 744 B-treatment

Planned 0 7 745 752 B-pregnancy
pregnancy 8 17 753 762 I-pregnancy
, 17 18 762 763 O
nursing 19 26 764 771 O
an 27 29 772 774 O
infant 30 36 775 781 O
, 36 37 781 782 O
confirmed 38 47 783 792 O
or 48 50 793 795 O
suspected 51 60 796 805 O
to 61 63 806 808 O
be 64 66 809 811 O
pregnant 67 75 812 820 B-pregnancy
between 76 83 821 828 O
screening 84 93 829 838 O
and 94 97 839 842 O
time 98 102 843 847 O
of 103 105 848 850 O
study 106 111 851 856 O
enrollment 112 122 857 867 O

Use 0 3 868 871 O
of 4 6 872 874 O
probiotics 7 17 875 885 B-treatment
or 18 20 886 888 O
antibiotics 21 32 889 900 B-treatment
in 33 35 901 903 O
the 36 39 904 907 O
past 40 44 908 912 B-upper_bound
30 45 47 913 915 I-upper_bound
days 48 52 916 920 I-upper_bound

illingness 0 10 921 931 O
to 11 13 932 934 O
take 14 18 935 939 O
IMM-124E 19 27 940 948 B-treatment
or 28 30 949 951 O
placebo 31 38 952 959 B-treatment
powder 39 45 960 966 I-treatment
3 46 47 967 968 O
x 48 49 969 970 O
daily 50 55 971 976 O
for 56 59 977 980 O
12 60 62 981 983 B-upper_bound
weeks 63 68 984 989 I-upper_bound

